CKD patients in hemodialysis. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: In experimental group: mix 2.5 ml ampule Cotrimoxazole ( 400/80) with 0.5 ml ampule heparin5000U then 1 ml distillated water added until total volume reach to 4 ml. In the end of dial
Treatment - Drugs
In experimental group: mix 2.5 ml ampule Cotrimoxazole ( 400/80) with 0.5 ml ampule heparin5000U then 1 ml distillated water added until total volume reach to 4 ml. In the end of dialysis section, ea
In Control group:1 ml of ampule heparin 5000 U with 3 ml distillated waterwill mix until total volume of 4 ml. In the end of dialysis section, each lumen of catheter were filled by this antibiotic so
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Recently diagnosed ESRD patients with temporary catheters. Exclusion criteria: active infection; Evidence of exit site of infection; Cirrhosis; encephalopathy; uncontrolled cancer; Any documented sensivity to sulfonamides family drugs.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Catheter related infection occurence. Timepoint: during 6 month study, weekly assessment. Method of measurement: lab data from blood sample, clinical observation, follow up by questioniare. | — |
Secondary
| Measure | Time frame |
|---|---|
| Any cause of bacteremia infection. Timepoint: during 6 month study. Method of measurement: clinical observation.;Thrombosis in catheter. Timepoint: during 6 month study. Method of measurement: clinical observation.;Any cause of hospitalization and length of hospitalization. Timepoint: during 6 month study. Method of measurement: clinical observation.;Any cause of catheter removement. Timepoint: during 6 month study. Method of measurement: clinical observation.;Any cause of mortality during study. Timepoint: during 6 month study. Method of measurement: clinical observation.;Exit-site infection. Timepoint: during 6 month study. Method of measurement: clinical observation.;Occurring of antibiotic resistance ( colony induction or resistance infection to antibiotic in lock solution). Timepoint: during 6 month study. Method of measurement: lab data from blood sample.;Fungal infection. Timepoint: during 6 month study. Method of measurement: lab data from blood sample.;Adverse effects of antibiotic. Timepoint: during 6 month study. Method of measurement: clinical observation.;Risk of unusual bleeding from catheter during dialysis. Timepoint: during 6 month study. Method of measurement: clinical observation. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed